Prof Richard Gibbs - Director, Baylor College of Medicine Human Genome Sequencing Centre
Wofford Cain Professor of Human & Molecular Genetics. http://www.garvan.org.au/news-events/leaders-in-science-and-society
The Human Genome Project was a 15-year scientific effort that mapped the entire human genome. It was primarily funded by governments in the US, UK, Japan, and other countries and cost $3 billion total. The project successfully identified the locations of all genes within human DNA and provided insights that enable genetically modifying crops, locating cancer cells, and diagnosing genetic diseases prenatally. Key techniques included genetic mapping to locate gene pairs on chromosomes and linkage analysis to determine the distance between disease-causing genes. The project's outcomes include further enabling gene therapy and precisely locating genes responsible for diseases.
This document contains the curriculum vitae of Kun Yang. It summarizes his education, research experience, publications, conference presentations, honors and awards. Yang received a B.S. in Biotechnology from Beijing Normal University in 2006, and is currently pursuing a Ph.D. in Pathobiology at Brown University, with a focus on epigenetic regulation of bone development and osteoarthritis. His research has identified miR-365 and the Ihh signaling pathway as critical regulators of bone mineral density and osteoarthritis.
This document summarizes research being conducted by Fanny Casado and her team on translational research of biomedical devices in Peru. The research includes:
1) Developing an advanced in vitro platform to study broiler chicken intestinal health and model coccidiosis, a parasitic disease affecting poultry.
2) Designing cost-effective wound dressings to promote chronic wound healing using endogenous growth factors.
3) Improving processing of cow intestines to supply safe raw materials for resorbable surgical sutures.
4) Creating an ultrasound-based tool to identify risk of diabetic foot ulcers in the Peruvian population.
Joel Aaron Trushinski is a student at the University of California Irvine studying microbiology with a 3.5 GPA. His career goal is to investigate interactions between the immune system and stem cells and their effects on injury regrowth. He has worked in two undergraduate research labs focusing on topics like DNA manipulation, neural stem cell culture, and spinal cord injuries. In addition to research, he has worked as a YMCA camp counselor and received multiple awards and grants for his academic and research accomplishments.
Whats Beyond The Finished Human Genome SequenceJohn Morgan
The document summarizes the progress and findings of the Human Genome Project from its inception in 1990 through its completion in 2003. It discusses how the project established the foundations for genetic mapping and sequencing chromosomes. After the working draft was announced in 2000 and the project was completed in 2003, subsequent research focused on fully sequencing and analyzing the remaining chromosomes. This led to insights into genetic diseases and variation in gene and chromatin distribution across chromosomes. The document also discusses subsequent projects like ENCODE and HapMap that built upon the human genome sequence to map functional elements and genetic variations respectively.
Oncology Discoveries, University of Chicagouchicagotech
The University of Chicago Comprehensive Cancer Center (UCCCC) uses cooperative, multidisciplinary initiatives to support innovative cancer research. It has over 320 active clinical trials spanning various phases, as well as core facilities that support research efforts. Research is organized into six scientific programs, including Molecular Mechanisms of Cancer and Hematopoiesis and Hematological Malignancies. These programs work to define the genetic causes of cancer and develop targeted therapies through translational research that moves between basic science and clinical applications. Representative technologies described include methods for inhibiting cancer metastasis and developing novel antibodies.
The Human Genome Project had several stated goals:
1) Identify all the approximately 20,000-25,000 genes in human DNA.
2) Determine the sequences of the 3 billion chemical base pairs that make up human DNA.
3) Store this information in databases.
4) Improve tools for data analysis.
5) Transfer related technologies to the private sector.
6) Address the ethical, legal, and social issues that may arise from the project.
The Human Genome Project was a 15-year scientific effort that mapped the entire human genome. It was primarily funded by governments in the US, UK, Japan, and other countries and cost $3 billion total. The project successfully identified the locations of all genes within human DNA and provided insights that enable genetically modifying crops, locating cancer cells, and diagnosing genetic diseases prenatally. Key techniques included genetic mapping to locate gene pairs on chromosomes and linkage analysis to determine the distance between disease-causing genes. The project's outcomes include further enabling gene therapy and precisely locating genes responsible for diseases.
This document contains the curriculum vitae of Kun Yang. It summarizes his education, research experience, publications, conference presentations, honors and awards. Yang received a B.S. in Biotechnology from Beijing Normal University in 2006, and is currently pursuing a Ph.D. in Pathobiology at Brown University, with a focus on epigenetic regulation of bone development and osteoarthritis. His research has identified miR-365 and the Ihh signaling pathway as critical regulators of bone mineral density and osteoarthritis.
This document summarizes research being conducted by Fanny Casado and her team on translational research of biomedical devices in Peru. The research includes:
1) Developing an advanced in vitro platform to study broiler chicken intestinal health and model coccidiosis, a parasitic disease affecting poultry.
2) Designing cost-effective wound dressings to promote chronic wound healing using endogenous growth factors.
3) Improving processing of cow intestines to supply safe raw materials for resorbable surgical sutures.
4) Creating an ultrasound-based tool to identify risk of diabetic foot ulcers in the Peruvian population.
Joel Aaron Trushinski is a student at the University of California Irvine studying microbiology with a 3.5 GPA. His career goal is to investigate interactions between the immune system and stem cells and their effects on injury regrowth. He has worked in two undergraduate research labs focusing on topics like DNA manipulation, neural stem cell culture, and spinal cord injuries. In addition to research, he has worked as a YMCA camp counselor and received multiple awards and grants for his academic and research accomplishments.
Whats Beyond The Finished Human Genome SequenceJohn Morgan
The document summarizes the progress and findings of the Human Genome Project from its inception in 1990 through its completion in 2003. It discusses how the project established the foundations for genetic mapping and sequencing chromosomes. After the working draft was announced in 2000 and the project was completed in 2003, subsequent research focused on fully sequencing and analyzing the remaining chromosomes. This led to insights into genetic diseases and variation in gene and chromatin distribution across chromosomes. The document also discusses subsequent projects like ENCODE and HapMap that built upon the human genome sequence to map functional elements and genetic variations respectively.
Oncology Discoveries, University of Chicagouchicagotech
The University of Chicago Comprehensive Cancer Center (UCCCC) uses cooperative, multidisciplinary initiatives to support innovative cancer research. It has over 320 active clinical trials spanning various phases, as well as core facilities that support research efforts. Research is organized into six scientific programs, including Molecular Mechanisms of Cancer and Hematopoiesis and Hematological Malignancies. These programs work to define the genetic causes of cancer and develop targeted therapies through translational research that moves between basic science and clinical applications. Representative technologies described include methods for inhibiting cancer metastasis and developing novel antibodies.
The Human Genome Project had several stated goals:
1) Identify all the approximately 20,000-25,000 genes in human DNA.
2) Determine the sequences of the 3 billion chemical base pairs that make up human DNA.
3) Store this information in databases.
4) Improve tools for data analysis.
5) Transfer related technologies to the private sector.
6) Address the ethical, legal, and social issues that may arise from the project.
Genomes 4 is a thoroughly updated textbook about genomes and how they are investigated. It covers genome sequencing, assembly, annotation, expression, replication, and evolution for viruses, bacteria, fungi, plants, animals, and humans. Some key techniques discussed include genome-wide RNA mapping, CRISPR-Cas 9, and GWAS for determining gene function. The book has 544 pages organized into chapters on genome techniques, structures, functions, and evolution with questions and further reading at the end of each chapter.
Genomes 4 is a thoroughly updated textbook about genomes and how they are investigated. It covers genome sequencing, assembly, annotation, expression, replication, and evolution for viruses, bacteria, fungi, plants, animals, and humans. The book is organized with techniques first, then genome structure, function, and evolution. It describes genome projects on humans, Neanderthals, pandas, and barley. Applications of transcriptomics, metabolomics, and systems biology are also discussed. Each chapter includes questions, problems, and further reading to aid student learning.
Genomes 4 is a thoroughly updated textbook about genomes and how they are investigated. It covers genome sequencing, assembly, annotation, expression, replication, and evolution for viruses, bacteria, fungi, plants, animals, and humans. Some key techniques discussed include genome-wide RNA mapping, CRISPR-Cas 9, and GWAS for determining gene function. The book has 544 pages organized into chapters on genome techniques, structures, functions, and evolution with questions and further reading at the end of each chapter.
Genomes 4 is a thoroughly updated textbook about genomes and how they are investigated. It covers genome sequencing, assembly, annotation, expression, replication, and evolution for viruses, bacteria, fungi, plants, animals, and humans. The book is organized with techniques first, then genome structure, function, and evolution. It describes genome projects on humans, Neanderthals, pandas, and barley. Applications of transcriptomics, metabolomics, and systems biology are also discussed. Each chapter includes questions, problems, and further reading to aid student learning.
This document summarizes the credentials and experience of Dun Li, Ph.D., a cancer biologist and research scientist. Li has over 10 years of experience in molecular biology, cancer research, and drug development. He is currently a postdoctoral fellow at Boston University developing transgenic zebrafish models of breast cancer, leukemia, and neuroblastoma. Previously, Li received his Ph.D. from Stony Brook University studying mutant p53 and cancer drug resistance. He has authored 7 peer-reviewed publications and received NIH training grants. Li is seeking a position where he can apply his expertise in cancer biology, molecular biology techniques, and animal model development.
Human genetic diversity and origin of major human groupsMayank Sagar
Humans are 99.9% genetically identical and yet we are all so different. Even monozygotic twins have infrequent genetic differences due to mutations occurring during development and gene copy-number variation.
Diabetes and Metabolic Disease Discoveries, University of Chicagouchicagotech
The document summarizes the Diabetes and Metabolic Disease research center at the University of Chicago. It describes their areas of expertise which include clinical research, genetics, biomarkers, immunology, islet biology, signal transduction, and type 2 diabetes and obesity. It provides examples of select research projects in each area aimed at developing new diagnostics, therapeutics, and treatment paradigms for diabetes and related conditions. It invites partnerships with industry to help translate innovations emerging from the center's research.
This document is a curriculum vitae for Todd C. Lorenz, Ph.D. It lists his education, professional appointments, teaching experience, publications, published genomes, research presentations, and grants. Lorenz received his Ph.D. in Biological Chemistry from UCLA and has worked as an Assistant Professor at the University of La Verne since 2012, where he teaches various biology courses.
Kelvin Yaprianto is a biochemist from Indonesia who received his Bachelor of Science with Honours degree from the Walter and Eliza Hall Institute of Medical Research in Australia in 2013. He has extensive research experience investigating the roles of NF-κB family transcription factors in promoting tumor cell survival and metastasis. Currently he works as a research assistant in stem cell and cancer research at PT. Kalbe Farma Tbk. in Jakarta.
The Meunier laboratory at the Queensland Brain Institute had a productive year in 2013. They were awarded two grants to fund their research into neuronal communication and survival. In 2013, the laboratory published eight papers investigating topics like the role of myosin VI in neuroexocytosis and the regulation of neuroexocytosis by Munc18-1. They also demonstrated that inhibition of PIKfyve activity leads to neuronal cell death by disrupting autophagy, implicating this pathway in neurodegenerative diseases. The laboratory continued to study vesicular trafficking and collaborated with other researchers on projects involving neurotoxin transport in neurons and dynamin inhibitors.
This document discusses recent technological developments in next-generation sequencing (NGS) applied to oncology. It describes how NGS has expanded in reliability, sequencing chemistry, data analysis, and decreased in cost. The document outlines the major steps in NGS including library preparation, sequencing, quality analysis, and data interpretation. It also discusses different NGS platforms and approaches like whole exome sequencing and whole genome sequencing. The document concludes that NGS has advanced the understanding of disease biology and has important clinical implications in fields like cancer diagnosis and personalized medicine.
A machine learning and bioinformatics approach was used to identify non-invasive miRNA biomarkers for early detection of non-small cell lung cancer (NSCLC). 13 miRNAs were found to be consistently underexpressed in NSCLC tissue, blood and serum across 4 datasets. Kaplan-Meier analysis showed 6 miRNAs had prognostic power. A random forest model identified a 3-miRNA panel (miR-320e, miR-103a, miR-526b) that detected NSCLC with 91.5% accuracy. These miRNAs were also prognostic for lung adenocarcinoma survival. An online tool called BiomarkerGenie was created to automate biomarker selection from omics data.
Cancer genome databases & Ecological databases Waliullah Wali
Introduction
Biological databases are libraries of life sciences information, collected from scientific experiments, published literature, high-throughput experiment technology, and computational analysis.
Information contained in biological databases includes gene function, structure, localization, clinical effects of mutations as well as similarities of biological sequences and structures.
Cancer genome databases
COSMIC cancer database
COSMIC cancer database
COSMIC is an online database of somatically acquired mutations found in human cancer.
The database is freely available.
COSMIC cancer database
Types of data
Expert curation data
Genome-wide screen data
COSMIC cancer database
Expert curation data
Manually input by COSMIC expert curators.
Consists of comprehensive literature curation followed by subsequent updates.
Includes additional data points relevant to each disease and publication.
Provides accurate frequency data as mutation negative samples are specified.
COSMIC cancer database
Genome-wide screen data
Uploaded from publications reporting large scale genome screening data or imported from other databases such as TCGA and ICGC.
Provides unbiased molecular profiling of diseases while covering the whole genome.
Provides objective frequency data by interpreting non mutant genes across each genome.
Facilitates finding novel driver genes in cancer.
Enter into -
COSMIC cancer database
by typing http://cancer.sanger.ac.uk/cosmic
in the address bar of Browser
Searching Process
Examples
Examples
Examples
Examples
Ecological databases
Ecological databases
Ecological databases is a source for finding ecological datasets and quickly figuring out the best ways to use them.
BioOne
DataONE
GEOBASE
BioOne
BioOne is a nonprofit publisher that aims to make scientific research more accessible.
BioOne was established in 1999 in Washington, DC.
BioOne is Complete and open-access.
It serves a community of over 140 society and institutional publishers, 4,000 accessing institutions, and millions of researchers worldwide.
Enter into -
BioOne Ecological database
by typing http://www.bioone.org/
in the address bar of Browser
Microbial Metagenomics Drives a New CyberinfrastructureLarry Smarr
06.03.03
Invited Talk
School of Biological Sciences
University of California, Irvine
Title: Microbial Metagenomics Drives a New Cyberinfrastructure
Irvine, CA
The researchers analyzed genomic data from 367 tissue samples from 18 locations and 20 ethnic groups in India and found evidence of 5 distinct ancestral components among the Indian population. They compared the Indian genomic data to the HUMAN GENOME DIVERSITY PANEL. In a separate study, scientists used algorithms to digitally analyze and sort cells by their cell cycle phase, providing a less toxic alternative to traditional staining methods. This new computational approach opens up opportunities for further cell cycle research and other areas of science. Studying genomic differences in populations can provide insights into disease susceptibility and help tailor medical treatments based on a person's ancestral origins and genome.
The document provides a summary of Swadesh Das's professional experience and qualifications. It summarizes that he has over 10 years of experience in research, particularly in microbiology and molecular oncology. He currently works as a research faculty at Virginia Commonwealth University, where he manages research projects and pursues patent applications. He has a PhD in Life Science and expertise in areas like molecular biology, cancer research, and biomarker identification.
The document summarizes key points about the human genome project and its impacts over the past 10 years as well as opportunities for the next 10 years. It discusses how the human genome project revealed the blueprint for building a human in 2001 and enabled greater understanding of gene functions and their medical impacts. It then outlines focus areas for genomic medicine in the coming decade like diagnostics, disease biology insights, cancer genome characterization, and clinical informatics. The role of the human microbiome in health and disease is also summarized along with challenges in bioinformatics like data analysis, integration and tools. Ethical and societal issues related to genomics research and medicine are also highlighted.
Presentation at the Canadian Cancer Research Conference satellite bioinformatics.ca workshop. This one is an introduction to tcga, icgc and cosmic databases.
The Cancer Imaging Archive (TCIA) is a large online archive of medical images and associated clinical data from cancer patients. It contains a variety of imaging modalities like CT, MRI, and PET scans covering many cancer types. The archive aims to support precision medicine by linking imaging data to molecular and genomic data from sources like The Cancer Genome Atlas. It provides a growing collection of over 40,000 subjects and 70 datasets that are frequently used in research publications and challenge competitions. The TCIA helps relieve researchers of data sharing burdens and provides hosting, de-identification, and support services to submitters and users of the archive.
Navigating the cancer maze 7. Professor Rajiv Khanna with Grace GawlerGracieG53
This document promotes the weekly radio show "Navigating the Cancer Maze" hosted by Grace Gawler. This week's guest is Professor Rajiv Khanna, a leading researcher at QIMR Berghofer Medical Research Institute who discusses promising results from world-first brain cancer immunotherapy trials. The show interviews leading cancer researchers, doctors, patients, and caregivers to provide information to help with cancer recovery. Listeners can tune in live or download interviews with experts discussing advances in immuno-therapies, targeted cancer therapies, and integrative approaches to managing cancer symptoms and side effects.
Timeline of Biotech development from 2003 to 2017Zohaib HUSSAIN
This document provides a timeline of key developments in biotechnology from 2003 to 2017. It discusses advances in areas like food/agriculture such as drought-resistant crops, medicine/physiology such as the discovery of RNA interference and stem cell reprogramming, and the history of the field including the sequencing of the rice genome in 2005 and 3D bioprinting in 2010. The timeline highlights over 50 specific discoveries, approvals, and other milestones that expanded the use and understanding of biotechnology over a 15 year period.
Genomes 4 is a thoroughly updated textbook about genomes and how they are investigated. It covers genome sequencing, assembly, annotation, expression, replication, and evolution for viruses, bacteria, fungi, plants, animals, and humans. Some key techniques discussed include genome-wide RNA mapping, CRISPR-Cas 9, and GWAS for determining gene function. The book has 544 pages organized into chapters on genome techniques, structures, functions, and evolution with questions and further reading at the end of each chapter.
Genomes 4 is a thoroughly updated textbook about genomes and how they are investigated. It covers genome sequencing, assembly, annotation, expression, replication, and evolution for viruses, bacteria, fungi, plants, animals, and humans. The book is organized with techniques first, then genome structure, function, and evolution. It describes genome projects on humans, Neanderthals, pandas, and barley. Applications of transcriptomics, metabolomics, and systems biology are also discussed. Each chapter includes questions, problems, and further reading to aid student learning.
Genomes 4 is a thoroughly updated textbook about genomes and how they are investigated. It covers genome sequencing, assembly, annotation, expression, replication, and evolution for viruses, bacteria, fungi, plants, animals, and humans. Some key techniques discussed include genome-wide RNA mapping, CRISPR-Cas 9, and GWAS for determining gene function. The book has 544 pages organized into chapters on genome techniques, structures, functions, and evolution with questions and further reading at the end of each chapter.
Genomes 4 is a thoroughly updated textbook about genomes and how they are investigated. It covers genome sequencing, assembly, annotation, expression, replication, and evolution for viruses, bacteria, fungi, plants, animals, and humans. The book is organized with techniques first, then genome structure, function, and evolution. It describes genome projects on humans, Neanderthals, pandas, and barley. Applications of transcriptomics, metabolomics, and systems biology are also discussed. Each chapter includes questions, problems, and further reading to aid student learning.
This document summarizes the credentials and experience of Dun Li, Ph.D., a cancer biologist and research scientist. Li has over 10 years of experience in molecular biology, cancer research, and drug development. He is currently a postdoctoral fellow at Boston University developing transgenic zebrafish models of breast cancer, leukemia, and neuroblastoma. Previously, Li received his Ph.D. from Stony Brook University studying mutant p53 and cancer drug resistance. He has authored 7 peer-reviewed publications and received NIH training grants. Li is seeking a position where he can apply his expertise in cancer biology, molecular biology techniques, and animal model development.
Human genetic diversity and origin of major human groupsMayank Sagar
Humans are 99.9% genetically identical and yet we are all so different. Even monozygotic twins have infrequent genetic differences due to mutations occurring during development and gene copy-number variation.
Diabetes and Metabolic Disease Discoveries, University of Chicagouchicagotech
The document summarizes the Diabetes and Metabolic Disease research center at the University of Chicago. It describes their areas of expertise which include clinical research, genetics, biomarkers, immunology, islet biology, signal transduction, and type 2 diabetes and obesity. It provides examples of select research projects in each area aimed at developing new diagnostics, therapeutics, and treatment paradigms for diabetes and related conditions. It invites partnerships with industry to help translate innovations emerging from the center's research.
This document is a curriculum vitae for Todd C. Lorenz, Ph.D. It lists his education, professional appointments, teaching experience, publications, published genomes, research presentations, and grants. Lorenz received his Ph.D. in Biological Chemistry from UCLA and has worked as an Assistant Professor at the University of La Verne since 2012, where he teaches various biology courses.
Kelvin Yaprianto is a biochemist from Indonesia who received his Bachelor of Science with Honours degree from the Walter and Eliza Hall Institute of Medical Research in Australia in 2013. He has extensive research experience investigating the roles of NF-κB family transcription factors in promoting tumor cell survival and metastasis. Currently he works as a research assistant in stem cell and cancer research at PT. Kalbe Farma Tbk. in Jakarta.
The Meunier laboratory at the Queensland Brain Institute had a productive year in 2013. They were awarded two grants to fund their research into neuronal communication and survival. In 2013, the laboratory published eight papers investigating topics like the role of myosin VI in neuroexocytosis and the regulation of neuroexocytosis by Munc18-1. They also demonstrated that inhibition of PIKfyve activity leads to neuronal cell death by disrupting autophagy, implicating this pathway in neurodegenerative diseases. The laboratory continued to study vesicular trafficking and collaborated with other researchers on projects involving neurotoxin transport in neurons and dynamin inhibitors.
This document discusses recent technological developments in next-generation sequencing (NGS) applied to oncology. It describes how NGS has expanded in reliability, sequencing chemistry, data analysis, and decreased in cost. The document outlines the major steps in NGS including library preparation, sequencing, quality analysis, and data interpretation. It also discusses different NGS platforms and approaches like whole exome sequencing and whole genome sequencing. The document concludes that NGS has advanced the understanding of disease biology and has important clinical implications in fields like cancer diagnosis and personalized medicine.
A machine learning and bioinformatics approach was used to identify non-invasive miRNA biomarkers for early detection of non-small cell lung cancer (NSCLC). 13 miRNAs were found to be consistently underexpressed in NSCLC tissue, blood and serum across 4 datasets. Kaplan-Meier analysis showed 6 miRNAs had prognostic power. A random forest model identified a 3-miRNA panel (miR-320e, miR-103a, miR-526b) that detected NSCLC with 91.5% accuracy. These miRNAs were also prognostic for lung adenocarcinoma survival. An online tool called BiomarkerGenie was created to automate biomarker selection from omics data.
Cancer genome databases & Ecological databases Waliullah Wali
Introduction
Biological databases are libraries of life sciences information, collected from scientific experiments, published literature, high-throughput experiment technology, and computational analysis.
Information contained in biological databases includes gene function, structure, localization, clinical effects of mutations as well as similarities of biological sequences and structures.
Cancer genome databases
COSMIC cancer database
COSMIC cancer database
COSMIC is an online database of somatically acquired mutations found in human cancer.
The database is freely available.
COSMIC cancer database
Types of data
Expert curation data
Genome-wide screen data
COSMIC cancer database
Expert curation data
Manually input by COSMIC expert curators.
Consists of comprehensive literature curation followed by subsequent updates.
Includes additional data points relevant to each disease and publication.
Provides accurate frequency data as mutation negative samples are specified.
COSMIC cancer database
Genome-wide screen data
Uploaded from publications reporting large scale genome screening data or imported from other databases such as TCGA and ICGC.
Provides unbiased molecular profiling of diseases while covering the whole genome.
Provides objective frequency data by interpreting non mutant genes across each genome.
Facilitates finding novel driver genes in cancer.
Enter into -
COSMIC cancer database
by typing http://cancer.sanger.ac.uk/cosmic
in the address bar of Browser
Searching Process
Examples
Examples
Examples
Examples
Ecological databases
Ecological databases
Ecological databases is a source for finding ecological datasets and quickly figuring out the best ways to use them.
BioOne
DataONE
GEOBASE
BioOne
BioOne is a nonprofit publisher that aims to make scientific research more accessible.
BioOne was established in 1999 in Washington, DC.
BioOne is Complete and open-access.
It serves a community of over 140 society and institutional publishers, 4,000 accessing institutions, and millions of researchers worldwide.
Enter into -
BioOne Ecological database
by typing http://www.bioone.org/
in the address bar of Browser
Microbial Metagenomics Drives a New CyberinfrastructureLarry Smarr
06.03.03
Invited Talk
School of Biological Sciences
University of California, Irvine
Title: Microbial Metagenomics Drives a New Cyberinfrastructure
Irvine, CA
The researchers analyzed genomic data from 367 tissue samples from 18 locations and 20 ethnic groups in India and found evidence of 5 distinct ancestral components among the Indian population. They compared the Indian genomic data to the HUMAN GENOME DIVERSITY PANEL. In a separate study, scientists used algorithms to digitally analyze and sort cells by their cell cycle phase, providing a less toxic alternative to traditional staining methods. This new computational approach opens up opportunities for further cell cycle research and other areas of science. Studying genomic differences in populations can provide insights into disease susceptibility and help tailor medical treatments based on a person's ancestral origins and genome.
The document provides a summary of Swadesh Das's professional experience and qualifications. It summarizes that he has over 10 years of experience in research, particularly in microbiology and molecular oncology. He currently works as a research faculty at Virginia Commonwealth University, where he manages research projects and pursues patent applications. He has a PhD in Life Science and expertise in areas like molecular biology, cancer research, and biomarker identification.
The document summarizes key points about the human genome project and its impacts over the past 10 years as well as opportunities for the next 10 years. It discusses how the human genome project revealed the blueprint for building a human in 2001 and enabled greater understanding of gene functions and their medical impacts. It then outlines focus areas for genomic medicine in the coming decade like diagnostics, disease biology insights, cancer genome characterization, and clinical informatics. The role of the human microbiome in health and disease is also summarized along with challenges in bioinformatics like data analysis, integration and tools. Ethical and societal issues related to genomics research and medicine are also highlighted.
Presentation at the Canadian Cancer Research Conference satellite bioinformatics.ca workshop. This one is an introduction to tcga, icgc and cosmic databases.
The Cancer Imaging Archive (TCIA) is a large online archive of medical images and associated clinical data from cancer patients. It contains a variety of imaging modalities like CT, MRI, and PET scans covering many cancer types. The archive aims to support precision medicine by linking imaging data to molecular and genomic data from sources like The Cancer Genome Atlas. It provides a growing collection of over 40,000 subjects and 70 datasets that are frequently used in research publications and challenge competitions. The TCIA helps relieve researchers of data sharing burdens and provides hosting, de-identification, and support services to submitters and users of the archive.
Navigating the cancer maze 7. Professor Rajiv Khanna with Grace GawlerGracieG53
This document promotes the weekly radio show "Navigating the Cancer Maze" hosted by Grace Gawler. This week's guest is Professor Rajiv Khanna, a leading researcher at QIMR Berghofer Medical Research Institute who discusses promising results from world-first brain cancer immunotherapy trials. The show interviews leading cancer researchers, doctors, patients, and caregivers to provide information to help with cancer recovery. Listeners can tune in live or download interviews with experts discussing advances in immuno-therapies, targeted cancer therapies, and integrative approaches to managing cancer symptoms and side effects.
Timeline of Biotech development from 2003 to 2017Zohaib HUSSAIN
This document provides a timeline of key developments in biotechnology from 2003 to 2017. It discusses advances in areas like food/agriculture such as drought-resistant crops, medicine/physiology such as the discovery of RNA interference and stem cell reprogramming, and the history of the field including the sequencing of the rice genome in 2005 and 3D bioprinting in 2010. The timeline highlights over 50 specific discoveries, approvals, and other milestones that expanded the use and understanding of biotechnology over a 15 year period.
The Human Genome Project was a 13-year international scientific research project that mapped and sequenced all of the genes of the human genome. It was completed in 2003 and has provided a foundation for scientific research into human health and disease. Some key outcomes of the project include identifying all of the approximately 20,000-25,000 genes that make up human DNA, determining the sequences of the 3 billion chemical base pairs in human DNA, and making this genomic data freely available online for scientific research. The project involved collaboration between research institutions in six countries and cost $3.8 billion, but it has generated an estimated $796 billion in economic impact by enabling new medical treatments and industries.
The document provides an overview of the Human Genome Project (HGP). The HGP was an international scientific research project that aimed to determine the sequence of nucleotide base pairs that make up human DNA and identify and map all human genes. The project began in 1990 and was completed in 2003, two years ahead of schedule. Key outcomes included identifying over 1800 disease genes, developing over 1000 genetic tests, and determining that the human genetic origin is from Africa. The project helped lay the groundwork for advances in personalized medicine.
Associate Professor Phillip Darcy has developed a novel approach to train white blood cells to better detect cancer cells by genetically modifying them to express chimeric antigen receptors that specifically recognize antigens on cancer cells. Testing in mouse models showed the modified white blood cells could effectively eradicate breast, sarcoma, and colon cancer cells without harming normal tissues. A phase I clinical trial is underway at Peter MacCallum Cancer Centre, with initial results showing the modified cells persisting for up to 10 months and homing in on cancer sites to mediate anti-tumor activity with no safety issues. This research aims to develop a new cancer therapy with few side effects compared to conventional treatments like chemotherapy and radiation.
This document provides an agenda and program details for a symposium on advances in childhood cancer hosted by Kids Cancer Alliance (KCA). The free event will be held on August 31, 2018 at the Australian National Maritime Museum and will feature talks on topics such as clinical application of whole genome sequencing, analysis of big data in pediatric cancers, cancer epigenetics, immunotherapies including CAR T cell therapy, and high dimensional analysis of single cell proteome data. Speakers include researchers from Australia, the US, and Switzerland with expertise in areas like cancer genomics, bioinformatics, immunology, and data science.
The document discusses the 100,000 Genomes Project in the Wessex region. It provides statistics on the number of rare disease participants and cancer patients sequenced so far in Wessex. It also gives an example of a Tier 1 variant finding in a gene called KDM5C that helped diagnose a patient's condition.
The Human Genome Project was a large, international collaborative project launched in 1990 with the main goal of determining the complete DNA sequence of human genes. It involved research groups from six countries and sought to map all human genes to further the study of genetic diseases. By 2003, the project had completed mapping over 99% of the human genome, finding that while genomes are over 99.9% identical, small differences of 0.1% can impact traits and disease susceptibility. The project provided tremendous medical implications, including enabling identification of disease genes and advancing fields like gene therapy and pharmacogenomics.
KCA Big Data and Immunotherapeutics Symposium, August 31st, 2018, SydneyMichael Evtushenko
Kids Cancer Alliance warmly invites you to this symposium featuring the latest developments in big data analytics, bioinformatics and, immunotherapeutic targeting.
An all-day symposium on the genomics of childhood cancer and germline predisposition, immune epitope targeting and CAR T cell therapeutics, and, single-cell transcriptomic and proteomic diagnostics in cancer.
For more details please contact Dr Michael Evtushenko MEvtushenko@ccia.unsw.edu.au
Medical biotechnology uses living cells and organisms to develop medical products and therapies. It has applications in areas like stem cell research, the Human Genome Project, recombinant DNA technology, gene therapy, vaccine development, insulin production, diagnostics, and genetic engineering. Some key contributions of medical biotechnology include completing the human genome sequence, producing the first genetically engineered human insulin to treat diabetes, and developing vaccines that have saved millions of lives.
The concept of the human microbiome was first suggested by Joshua Lederberg, who coined the term ‘‘microbiome, to signify the ecological community of commensal, symbiotic, and pathogenic microorganisms that literally share our body space’’
Scientists have made progress in mapping the cancer genome and identifying genetic markers for lupus. A study identified many new genetic markers for lupus by analyzing over 27,000 people of European, African, and Hispanic descent. Separately, scientists evaluated algorithms used to analyze the cancer genome, finding that subgene algorithms provide a high-resolution view of how mutations in the same gene can lead to different health outcomes depending on location. Genetic mapping provides medical utility by aiding the discovery of drug targets and enabling targeted research in populations with high disease risk.
Evolution of dental informatics as a major researchGaurav Salunkhe
This document discusses the evolution of dental informatics as a major research tool in oral pathology. It describes how dental informatics incorporates knowledge from various fields like health science, computer science, and information technology. The primary goals are to increase understanding of biological processes and improve patient outcomes. Major areas of research include gene finding, genome assembly, protein structure prediction, and drug design. Applications discussed include using microarrays and genomics/proteomics for early oral cancer detection, identifying genetic factors that influence disease progression, and cataloging proteins in oral fluids. The conclusion states that combining experimental and theoretical approaches from various disciplines like bioinformatics will provide better understanding of oral diseases at the molecular level.
Join us in Boston this coming Fall to attend Cambridge Healthtech Institute's (CHI) 2nd Annual FAST: Functional Analysis & Screening Technologies Congress on November 17-19, 2014 and meet with a community of 250+ biologists, screening managers, assay developers, engineers and pharmacologists dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development at 6 conferences: Phenotypic Drug Discovery (Part I & II), Engineering Functional 3D Models, Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology and Physiologically-Relevant Cellular Tumor Models for Drug Discovery. Delegates have the opportunity to share insights in interactive panel discussions and connect during networking breaks. View innovative technologies and scientific research revolutionizing early-stage drug discovery in the exhibit/poster hall.
The document provides updates from various departments at the Kimmel Cancer Center. It announces new treatments for prostate cancer including high intensity focused ultrasound. It highlights advances in areas like radiation oncology, integrative medicine, and stem cell research. It recognizes support from donors and announces new rankings for cancer care.
The document discusses the history and progress of medicine and genomics over the past century. It describes how the human genome was sequenced between 2000-2003 and how this sparked the rise of omics technologies and new databases. It also discusses how microarray testing in 2012 revealed two subtypes of diffuse large B cell lymphoma that respond differently to treatments, representing an early achievement of precision medicine. The document advocates that clinical lab scientists help make precision diagnostic tests more widely accessible and efficient to improve health outcomes.
iOncologi_Pitch Deck_2024 slide show for hostingerssuser9354ce
iOncologi is developing novel cancer immunotherapies including stem cell therapies and mRNA-nanoparticle vaccines. Their stem cell therapy has shown ability to overcome resistance to immune checkpoint inhibitors in preclinical studies and received FDA approval for clinical trials in glioblastoma patients. Their mRNA-NP vaccine platform is in early phase clinical trials for refractory solid cancers. iOncologi seeks capital to further clinical evaluation and develop allogeneic 'off-the-shelf' stem cell therapies.
The document discusses the intersection of precision medicine, biomarkers, and healthcare policy. It describes how biomarkers and -omics data can be used for precision medicine to improve diagnostic accuracy, deliver targeted therapies, and stratify patient populations. However, clinical validation of biomarkers now requires large datasets and years of studies due to regulatory and payer requirements. This has reduced incentives for diagnostic innovation. The document also discusses challenges around clinical interpretation of complex multi-omic tests, evolving medical training and workflows, and disconnects between patent and reimbursement policies.
Similar to Leaders in Science and Society - Prof Richard Gibbs (20)
Professor Gail Risbridger. Deputy Dean - Special Projects, MpCCC Research Director, Prostate Cancer Research Program, Monash University. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Scientia Professor Katharina Gaus - EMBL Australia Node in Single Molecule Science, ARC Centre of Excellence in Advanced Molecular Imaging, University of New South Wales. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Dr Kate Schroder - Deputy Director, IMB Centre for Inflammation and Disease Research, Institute for Molecular Bioscience. http://www.garvan.org.au/news-events/leaders-in-science-and-societ
Professor Philip E Scherer, Touchstone Diabetes Center, UT Southwestern Medical Center, Dallas // Assistant Professor Janelle Ayres, Nomis Center for Immunobiology & Microbial Pathogenesis, The Salk Institute of Biological Studies // Professor Jorge Ferrer, Faculty of Medicine, Department of Medicine, Imperial College London
Professor Louisa Jorm - Director, Centre for Big Data Research in Health, UNSW Australia. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Professor Christina Mitchell will give a presentation titled "Regulation of Phosphoinositide 3-kinase signaling by Phosphoinositide Phosphatases" on June 20th at 12PM in the Auditorium. Professor Mitchell is the Academic Vice-President and Dean of the Faculty of Medicine, Nursing and Health Sciences at Monash University. She trained as a physician scientist specializing in clinical haematology and was the first woman appointed Dean of Medicine at a Group of Eight university in Australia.
Dr. Roberto Weigert will give a presentation titled "Molecular Mechanism of Membrane remodeling in Live Animals by Subcellular Intravital Microscopy". He is a Senior Investigator at the National Cancer Institute and National Institute of Dental and Craniofacial Research. Using subcellular intravital microscopy, his research studies membrane remodeling during trafficking events in live animals.
Charles Curran, who has extensive experience in Australian business and public life, will give a talk reflecting on economic and political developments in Australia over the last 50 years. As the Chairman of Capital Investment Group and a member of Goldman Sachs' International Board of Advisors, Curran has chaired or been a director of several public companies. He has also held leadership roles in many community organizations, including as Chairman of the Garvan Institute of Medical Research and St Vincent's Hospital Sydney.
Professor Yoshihide Hayashizaki, Program Director, Preventative Medicine and Diagnosis Innovation
Program, RIKEN, Japan. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Peter Vogt, a professor at The Scripps Research Institute, will give a lecture titled "MYC and the Non-coding Transcriptome" at the Garvan Institute of Medical Research on November 9, 2015. Vogt was trained as a virologist in Germany and California and his work focuses on retroviral replication, viral and cellular oncogenes, and identifying inhibitors of oncoproteins. He has held faculty positions at several universities and is currently a professor at The Scripps Research Institute studying MYC and non-coding RNA transcripts.
Professor Rob Parton - Institute for Molecular Bioscience
University of Queensland. http://www.garvan.org.au/news-events/leaders-in-science-and-society
Professor Carolyn Sue, Professor University of Sydney / Director of the Department of Neurogenetics at Royal North Shore Hospital / Director of the National Centre for Adult Stem Cell Research (Sydney Node). http://www.garvan.org.au/news-events/leaders-in-science-and-society
Professor Joe Trapani, Executive Director Cancer Research,
Peter MacCallum Cancer Centre, Melbourne. http://www.garvan.org.au/news-events/leaders-in-science-and-society
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...Scintica Instrumentation
Targeting Hsp90 and its pathogen Orthologs with Tethered Inhibitors as a Diagnostic and Therapeutic Strategy for cancer and infectious diseases with Dr. Timothy Haystead.
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfSelcen Ozturkcan
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
Immersive Learning That Works: Research Grounding and Paths ForwardLeonel Morgado
We will metaverse into the essence of immersive learning, into its three dimensions and conceptual models. This approach encompasses elements from teaching methodologies to social involvement, through organizational concerns and technologies. Challenging the perception of learning as knowledge transfer, we introduce a 'Uses, Practices & Strategies' model operationalized by the 'Immersive Learning Brain' and ‘Immersion Cube’ frameworks. This approach offers a comprehensive guide through the intricacies of immersive educational experiences and spotlighting research frontiers, along the immersion dimensions of system, narrative, and agency. Our discourse extends to stakeholders beyond the academic sphere, addressing the interests of technologists, instructional designers, and policymakers. We span various contexts, from formal education to organizational transformation to the new horizon of an AI-pervasive society. This keynote aims to unite the iLRN community in a collaborative journey towards a future where immersive learning research and practice coalesce, paving the way for innovative educational research and practice landscapes.
ESR spectroscopy in liquid food and beverages.pptxPRIYANKA PATEL
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...Sérgio Sacani
Context. With a mass exceeding several 104 M⊙ and a rich and dense population of massive stars, supermassive young star clusters
represent the most massive star-forming environment that is dominated by the feedback from massive stars and gravitational interactions
among stars.
Aims. In this paper we present the Extended Westerlund 1 and 2 Open Clusters Survey (EWOCS) project, which aims to investigate
the influence of the starburst environment on the formation of stars and planets, and on the evolution of both low and high mass stars.
The primary targets of this project are Westerlund 1 and 2, the closest supermassive star clusters to the Sun.
Methods. The project is based primarily on recent observations conducted with the Chandra and JWST observatories. Specifically,
the Chandra survey of Westerlund 1 consists of 36 new ACIS-I observations, nearly co-pointed, for a total exposure time of 1 Msec.
Additionally, we included 8 archival Chandra/ACIS-S observations. This paper presents the resulting catalog of X-ray sources within
and around Westerlund 1. Sources were detected by combining various existing methods, and photon extraction and source validation
were carried out using the ACIS-Extract software.
Results. The EWOCS X-ray catalog comprises 5963 validated sources out of the 9420 initially provided to ACIS-Extract, reaching a
photon flux threshold of approximately 2 × 10−8 photons cm−2
s
−1
. The X-ray sources exhibit a highly concentrated spatial distribution,
with 1075 sources located within the central 1 arcmin. We have successfully detected X-ray emissions from 126 out of the 166 known
massive stars of the cluster, and we have collected over 71 000 photons from the magnetar CXO J164710.20-455217.
Juaristi, Jon. - El canon espanol. El legado de la cultura española a la civi...
Leaders in Science and Society - Prof Richard Gibbs
1. Garvan Institute of Medical Research
Leaders in Science & Society
Prof Richard Gibbs
Director, Baylor College of Medicine Human Genome Sequencing Centre
Wofford Cain Professor of Human & Molecular Genetics
“Precision Medical Research”
Monday 30 May 2016 12PM, AUDITORIUM
Host: Prof John Mattick
Richard Gibbs was born in Australia and graduated from Melbourne University and the Peter MaCallum Cancer Institute in 1986 in Genetics and Radiation Biology. He moved
to the USA to Baylor College of Medicine, where he performed key work on the molecular characterization of human genetic disease and provided an early leadership role for
the Human Genome Project. In 1997 he founded the BCM Human Genome Sequencing Center – the HGSC – that was one of five main groups to complete the HGP. The HGSC
then completed the genomes of many model species and provided leadership for other international projects, including the Mammalian Gene Collection, the Hapmap Project,
the 1000 Genomes Project and the Cancer Genome Atlas. The HGSC has also been a technology leader, including developing the DNA exome capture technologies now used
ubiquitously.
The HGSC continues to work on large scale comparative genomics and development of genome technologies. Beginning in 2007 the group developed the field of personal
human genomics, beginning with personal genome sequences of James Watson and James Lupski and culminating with creation of the first Genetics Diagnostics Laboratory to
be based on whole gene sequencing. He now leads the HGSC efforts in large scale clinical translation.
Gibbs has served on many NIH Advisory Councils and was elected to the National Academy of Medicine in 2011, named an Honorary Fellow of the Royal College of Pathologists
of Australasia in 2011 and recognized as one of the 400 most influential biomedical scientists in the world in 2013 (Eur J. Clin. Invest. 2014). He is currently the Wofford Cain
Distinguished Professor of Molecular and Human Genetics and Director of the HGSC.